Biotech & Life Sciences hub: 106 startups and 54 funds matched in our directory. Search the full startup corpus from /startups.
Venture Capital Tracker logo
Venture Capital Tracker

Biotech & Life Sciences startups and investors we cover

Shortlist companies and funds tagged Biotech & Life Sciences in our directory. This hub is a sector cut, not a complete market census. Search every startup from /startups or open the investor list.

Startups in this sector

Showing 12 of 106 matched profiles.

  • TriGemX Bio

    Late-stage migraine biotech developing elismetrep, an oral TRPM8 channel blocker.

  • NorthStar Medical Technologies

    Radiopharmaceutical infrastructure company producing medical radioisotopes and providing clinical and commercial drug-manufacturing services.

  • AnaCardio

    Clinical-stage cardiovascular biotech developing AC01, an oral ghrelin-receptor agonist for chronic advanced heart failure.

  • Varda Space Industries

    Microgravity-enabled life-sciences company manufacturing pharmaceutical materials in orbit and returning them to Earth.

  • R1 Therapeutics

    Clinical-stage kidney-disease therapeutics company developing AP306

  • ArkeaBio

    Climate-biotech company developing vaccines intended to reduce methane emissions from livestock.

  • Astromech

    Colossal spinout building predictive models of biology using evolutionary and genomic data.

  • Boltz

    MIT-founded biotech applying open AI protein models to lab deployment (public-benefit corp).

  • Adaptyv

    YC S21 automated wet lab that synthesizes and tests AI-designed proteins and returns experimental data.

  • AusperBio

    Clinical-stage oligonucleotide company developing ASO and targeted-siRNA candidates aimed at a functional cure for chronic hepatitis B.

  • Anagram Therapeutics

    Clinical-stage biotech developing non-porcine oral enzyme therapies to replace 15–40 daily pills for pancreatic insufficiency.

  • Aureka Biotechnologies

    AI-native TechBio building biological foundation models with closed-loop wet-lab infrastructure.

Investors in this sector

Showing 12 of 54 matched funds.

  • ARCH Venture Partners

    Chicago-based life-sciences specialist that co-founds and funds seed through growth-stage biotech and deep-science companies, often originating companies directly from academic research.

  • Abstract Ventures

    Abstract is a San Francisco venture capital firm investing across seed and early-stage technology companies. The firm reports $3.3 billion in assets under management and participated in Volantis's $88 million Series A.

  • AgriZeroNZ

    New Zealand agritech investment company focused on technologies that can reduce agricultural greenhouse-gas emissions. It led ArkeaBio’s $15 million Series A2 in September 2026.

  • Arboretum Ventures

    Ann Arbor healthcare VC founded 2002. Manages ~$1B across six funds; Fund VI closed at $268M (June 2023). Focus: medical devices, life science tools & diagnostics, tech-enabled care, pharma adjacencies — with preference for under-ventured geographies including the Midwest. Main office: First National Building, 201 S. Main Street, Suite 300, Ann Arbor, MI 48104.

  • Atlas Venture

    Cambridge, MA–based biotech venture firm that creates and builds early-stage life-sciences companies, partnering with scientists from company formation through Series A.

  • BioGenerator Ventures

    St. Louis company-creation and early-stage investor focused on healthcare and agriculture. Part of the BioSTL ecosystem; BioGenerator dates to 2003 as a regional life-science formation engine. BioGenerator Ventures builds companies from concepts/EIRs, invests from an evergreen model, and syndicates with national venture and strategic capital. Sectors: therapeutics, diagnostics, research tools, and agtech. HQ St. Louis, MO.

  • Breakthrough Energy Ventures

    Climate-technology venture fund within Breakthrough Energy, investing in technologies capable of materially reducing greenhouse-gas emissions. It backed ArkeaBio’s Series A and Series A2 financings.

  • Buffalo Innovation Seed Fund

    $10M evergreen early-stage fund affiliated with University at Buffalo Startup Ventures; capitalized via New York State ESD Innovation Hub and the SUNY Research Foundation. Cultivator investments up to $100k; Seed investments up to $250k with a 1:1 match requirement to non-NYS funds.

  • Chrysalis Ventures

    Louisville-based venture firm investing in healthcare and technology companies across the Midwest and South. Long-running Kentucky institutional VC presence.

  • CincyTech

    Cincinnati seed-stage firm and one of the Midwest’s most active seed investors, supported by Ohio Third Frontier and founding partners including Cincinnati Children’s, University of Cincinnati, and the Cincinnati USA Regional Chamber. Address: 2900 Reading Rd. Ste. 410, Cincinnati, OH 45206.

  • Clarevia Ventures

    Midwest healthcare VC formerly Venture Investors Health Fund (founded 1984). ~$350M AUM. Madison HQ at University Research Park (510 Charmany Drive, Suite 250, Madison, WI 53719) with Ann Arbor and Milwaukee offices. Early-stage medtech and life sciences.

  • Cottonwood Technology Fund

    Southwest deep-tech venture firm (founded 2010) investing in patent-based hard science at pre-seed and seed — photonics, advanced materials, nanotechnology, robotics, medical technology, and climate hardware. Offices in Santa Fe, Denver, and the Netherlands; Fund IV first close March 2025 targeting $80M.